Suchergebnisse - "Borghi, V"

PubPharm (126)

1

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2023

von Armenia, D. | Gagliardini, R. | Alteri, C. | +17

2

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens : A Prospective RESPOND Cohort Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Álvarez, H. | Mocroft, A. | Ryom, L. | +130

3

Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Ciccullo, A. | Baldin, G. | Borghi, V. | +11

4

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

enthalten in: HIV medicine | 2022

von Byonanebye, D. | Polizzotto, M. | Neesgaard, B. | +90

5

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting

enthalten in: Open forum infectious diseases | 2022

von Greenberg, L. | Ryom, L. | Neesgaard, B. | +130

6

Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies : a multi-cohort study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Borghetti, A. | Alkhatib, M. | Dusina, A. | +4

7

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Greenberg, L. | Ryom, L. | Neesgaard, B. | +140

8

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors

enthalten in: HIV medicine | 2021

von Borghetti, A. | Ciccullo, A. | Lombardi, F. | +10

9

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment

enthalten in: HIV medicine | 2020

von Mocroft, A. | Neesgard, B. | Zangerle, R. | +29

10

HIV MDR is still a relevant issue despite its dramatic drop over the years

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Armenia, D. | Di Carlo, D. | Flandre, P. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]